198 related articles for article (PubMed ID: 29926872)
21. Taribavirin and 5-Fluorouracil-Loaded Pegylated-Lipid Nanoparticle Synthesis, p38 Docking, and Antiproliferative Effects on MCF-7 Breast Cancer.
Abd-Rabou AA; Bharali DJ; Mousa SA
Pharm Res; 2018 Feb; 35(4):76. PubMed ID: 29488022
[TBL] [Abstract][Full Text] [Related]
22. Comparison, synthesis and evaluation of anticancer drug-loaded polymeric nanoparticles on breast cancer cell lines.
Eatemadi A; Darabi M; Afraidooni L; Zarghami N; Daraee H; Eskandari L; Mellatyar H; Akbarzadeh A
Artif Cells Nanomed Biotechnol; 2016 May; 44(3):1008-17. PubMed ID: 25707442
[TBL] [Abstract][Full Text] [Related]
23. Lactoferrin nanoparticle mediated targeted delivery of 5-fluorouracil for enhanced therapeutic efficacy.
Kumari S; Kondapi AK
Int J Biol Macromol; 2017 Feb; 95():232-237. PubMed ID: 27864056
[TBL] [Abstract][Full Text] [Related]
24. Controllable porosity conversion of metal-organic frameworks composed of natural ingredients for drug delivery.
Liu J; Bao TY; Yang XY; Zhu PP; Wu LH; Sha JQ; Zhang L; Dong LZ; Cao XL; Lan YQ
Chem Commun (Camb); 2017 Jul; 53(55):7804-7807. PubMed ID: 28653075
[TBL] [Abstract][Full Text] [Related]
25. Stealth recombinant human serum albumin nanoparticles conjugating 5-fluorouracil augmented drug delivery and cytotoxicity in human colon cancer, HT-29 cells.
Sharma A; Kaur A; Jain UK; Chandra R; Madan J
Colloids Surf B Biointerfaces; 2017 Jul; 155():200-208. PubMed ID: 28431329
[TBL] [Abstract][Full Text] [Related]
26. Carboxymethylcellulose-coated 5-fluorouracil@MOF-5 nano-hybrid as a bio-nanocomposite carrier for the anticancer oral delivery.
Javanbakht S; Hemmati A; Namazi H; Heydari A
Int J Biol Macromol; 2020 Jul; 155():876-882. PubMed ID: 31805324
[TBL] [Abstract][Full Text] [Related]
27. A polymeric prodrug of 5-fluorouracil-1-acetic acid using a multi-hydroxyl polyethylene glycol derivative as the drug carrier.
Li M; Liang Z; Sun X; Gong T; Zhang Z
PLoS One; 2014; 9(11):e112888. PubMed ID: 25389968
[TBL] [Abstract][Full Text] [Related]
28. Metal organic framework-based polymeric hydrogel: A promising drug delivery vehicle for the treatment of breast cancer.
Pandya I; Kumar S; Aswal VK; El Seoud O; Assiri MA; Malek N
Int J Pharm; 2024 Jun; 658():124206. PubMed ID: 38734276
[TBL] [Abstract][Full Text] [Related]
29. Investigation of Binding Behavior between Drug Molecule 5-Fluoracil and M
Xu WQ; Fan YZ; Wang HP; Teng J; Li YH; Chen CX; Fenske D; Jiang JJ; Su CY
Chemistry; 2017 Mar; 23(15):3542-3547. PubMed ID: 28094459
[TBL] [Abstract][Full Text] [Related]
30. Improvement of pharmacokinetic and antitumor activity of layered double hydroxide nanoparticles by coating with PEGylated phospholipid membrane.
Yan M; Zhang Z; Cui S; Lei M; Zeng K; Liao Y; Chu W; Deng Y; Zhao C
Int J Nanomedicine; 2014; 9():4867-78. PubMed ID: 25364245
[TBL] [Abstract][Full Text] [Related]
31. Glutathione-responsive nanoscale MOFs for effective intracellular delivery of the anticancer drug 6-mercaptopurine.
Gong M; Yang J; Li Y; Gu J
Chem Commun (Camb); 2020 Jun; 56(47):6448-6451. PubMed ID: 32393947
[TBL] [Abstract][Full Text] [Related]
32. Supramolecular cyclodextrin-based metal-organic frameworks as efficient carrier for anti-inflammatory drugs.
Abuçafy MP; Caetano BL; Chiari-Andréo BG; Fonseca-Santos B; do Santos AM; Chorilli M; Chiavacci LA
Eur J Pharm Biopharm; 2018 Jun; 127():112-119. PubMed ID: 29428794
[TBL] [Abstract][Full Text] [Related]
33. A Luminescent Amine-Functionalized Metal-Organic Framework Conjugated with Folic Acid as a Targeted Biocompatible pH-Responsive Nanocarrier for Apoptosis Induction in Breast Cancer Cells.
Abazari R; Ataei F; Morsali A; Slawin AMZ; L Carpenter-Warren C
ACS Appl Mater Interfaces; 2019 Dec; 11(49):45442-45454. PubMed ID: 31718155
[TBL] [Abstract][Full Text] [Related]
34. Diiodo-Bodipy-Encapsulated Nanoscale Metal-Organic Framework for pH-Driven Selective and Mitochondria Targeted Photodynamic Therapy.
Guan Q; Zhou LL; Li YA; Dong YB
Inorg Chem; 2018 Aug; 57(16):10137-10145. PubMed ID: 30074794
[TBL] [Abstract][Full Text] [Related]
35. Glutathione responsive cubic gel particles cyclodextrin metal-organic frameworks for intracellular drug delivery.
Xue Q; Ye C; Zhang M; Hu X; Cai T
J Colloid Interface Sci; 2019 Sep; 551():39-46. PubMed ID: 31075632
[TBL] [Abstract][Full Text] [Related]
36. Flow field-flow fractionation and multi-angle light scattering as a powerful tool for the characterization and stability evaluation of drug-loaded metal-organic framework nanoparticles.
Roda B; Marassi V; Zattoni A; Borghi F; Anand R; Agostoni V; Gref R; Reschiglian P; Monti S
Anal Bioanal Chem; 2018 Aug; 410(21):5245-5253. PubMed ID: 29947896
[TBL] [Abstract][Full Text] [Related]
37. Targeted Drug Delivery in Covalent Organic Nanosheets (CONs) via Sequential Postsynthetic Modification.
Mitra S; Sasmal HS; Kundu T; Kandambeth S; Illath K; Díaz Díaz D; Banerjee R
J Am Chem Soc; 2017 Mar; 139(12):4513-4520. PubMed ID: 28256830
[TBL] [Abstract][Full Text] [Related]
38. MOF × Biopolymer: Collaborative Combination of Metal-Organic Framework and Biopolymer for Advanced Anticancer Therapy.
Kim K; Lee S; Jin E; Palanikumar L; Lee JH; Kim JC; Nam JS; Jana B; Kwon TH; Kwak SK; Choe W; Ryu JH
ACS Appl Mater Interfaces; 2019 Aug; 11(31):27512-27520. PubMed ID: 31293157
[TBL] [Abstract][Full Text] [Related]
39. Sequential delivery of synergistic drugs by silica nanocarriers for enhanced tumour treatment.
Birault A; Giret S; Théron C; Gallud A; Da Silva A; Durand D; Nguyen C; Bettache N; Gary-Bobo M; Bartlett JR; Wong Chi Man M; Carcel C
J Mater Chem B; 2020 Feb; 8(7):1472-1480. PubMed ID: 31995094
[TBL] [Abstract][Full Text] [Related]
40. Core-Shell Nanosystems for Self-Activated Drug-Gene Combinations against Triple-Negative Breast Cancer.
Liu P; Liu X; Cheng Y; Zhong S; Shi X; Wang S; Liu M; Ding J; Zhou W
ACS Appl Mater Interfaces; 2020 Dec; 12(48):53654-53664. PubMed ID: 33205940
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
